Medical Imaging in Illinois

Ecomed Solutions is a medical device company specializing in innovative, cost-effective products for healthcare providers and medical device manufacturers. The company operates as a contract manufacturer, private-label producer, and new product development partner for the medical device industry. Primary product lines include diagnostic imaging syringes compatible with leading injector systems (Mark V Plus, Mark V ProVis, Stellant), blood management solutions (HemaSavr line for reducing allogeneic transfusions), and maternal/neonatal wellness products (SureGlide line). The company serves healthcare systems, imaging centers, and OEM partners requiring high-quality medical consumables and specialized devices. Ecomed Solutions emphasizes quality, regulatory compliance, and patient care improvement across its product portfolio. The company offers end-to-end services including contract manufacturing with custom formulations, private-label manufacturing for partner brands, and collaborative new product development for emerging market needs.

MinXray, Inc. (established 1967) is a leading manufacturer of portable, compact, and mobile X-ray equipment and digital radiography systems. Based in Northbrook, Illinois, the company specializes in field-transportable digital imaging solutions for medical, veterinary, military, and global health applications. MinXray's lightweight, rapidly deployable systems are engineered for onsite imaging in environments where conventional large-format units are impractical—including nursing homes, emergency response, prisons, remote clinics, cruise ships, and military field operations. The company's IMPACT wireless system combines digital radiography with portable ultrasound technology, serving general medical, emergency care, sports medicine, and facility safety markets. MinXray also supports companion animals, equine/large animal, mixed animal, and zoo/marine veterinary imaging. The company has demonstrated innovation through collaborations including NASA space-based medical X-ray imaging and AI-powered tuberculosis screening in Nepal. With a commitment to responsive customer support and rapid equipment deployment, MinXray enables diagnostic imaging in 90+ countries.

SimBioSys develops cloud-based AI and spatial biophysics software for precision cancer visualization, diagnosis, and treatment planning. The company's core technology combines artificial intelligence, spatial biophysics, and data science to segment tumors and create interactive 3D digital models from medical imaging (primarily DCE-MRI), addressing tumor heterogeneity beyond traditional 2D pathology. TumorSight Viz is the company's flagship product—FDA-cleared for breast cancer surgical planning and preoperative assessment. It transforms 2D MRI studies into 3D visualizations with volumetric calculations and anatomical measurements to support breast conservation decisions. Additional clinical solutions in development include TumorSight Plan (surgical guidance), TumorSight IQ (treatment response prediction), TumorSight Risk (recurrence risk assessment), TumorSight Marker (biomarker selection), and TumorSight Dose (therapeutic dosing). PhenoScope is a research platform supporting biomarker discovery, optimal dosing, combination therapy analysis, and indication expansion. The company serves breast surgeons, oncologists, academic medical centers, and biopharma researchers. Institutional partnerships include Baylor College of Medicine, NYU Langone Health, Yale Medicine, and NorthShore Health. The technology leverages NVIDIA infrastructure for 3D model generation. While TumorSight Viz holds FDA clearance, most advanced clinical applications remain investigational. SimBioSys positions itself at the intersection of precision medicine, surgical planning, and AI-driven oncology diagnostics.